Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2023 Earnings

Operator: Good morning. My name is Jason and I will be your conference operator today.

Related Keywords

United States , Maury Raycroft , Nicole Gabreski , Michael Mason , Reshma Rangwala , Piper Sandler , Deric Joseph , Chris Raymond , Kevin Strang , Elhan Webb , Richard Paulson , Brian Abrams , Jonathan Chang , Mike Todd , Sohanya Cheng , Colleen Kusy , Peter Lawson , Assistance Program , Barclays , Nasdaq , European Network For Gynecological Oncological Trial Group , Patient Assistance Program , Karyopharm Therapeutics Inc , Gynecology Oncology Group , Karyopharm Therapeutics , Call Transcript August , Karyopharm Therapeutics Second Quarter , Results Conference , Senior Vice President , Safe Harbor , Private Securities Litigation Reform Act , Risk Factors , Fast Track , European Network , Gynecological Oncological Trial Group , Gynecology Oncology ,